Background: Cashew nut allergy is an emerging food allergy with a high risk of systemic anaphylaxis. Currently, an adjuvant-free animal model to study cashew nut allergy is not available. Methods: BALB/c mice were exposed to cashew nut protein using a transdermal sensitization protocol that does not use adjuvant. Systemic IgE antibody response, systemic anaphylaxis to oral challenge and allergen-driven, spleen-cell, type-2 cytokine responses were studied. Results: Transdermal exposure to cashew nut resulted in a significant dose-dependent allergic response. Oral challenge of sensitized mice with cashew resulted in severe signs of systemic anaphylaxis and a significant hypothermia. Spleen cell culture with cashew nut protein resulted in allergen-driven IL-4, IL-5 and IL-13 responses only in sensitized but not in saline control mice. Conclusions: These data demonstrate that (i) transdermal exposure to cashew nut protein elicits a robust IgE response leading to clinical sensitization of mice for systemic anaphylaxis to oral cashew nut challenge; (ii) cashew nut is a potent activator of type-2 cytokines, thus explaining the mechanism of cashew allergy, and (iii) this mouse model may be useful for further basic and preclinical studies on cashew nut allergy.

Keywords:
Adjuvant, Cashew nut allergy, Cytokines, Food allergy, IgE, Mouse model, Systemic anaphylaxis, Th2
1.
Sampson HA: Update on food allergy. J Allergy Clin Immunol 2004;113:805–819.
2.
Bernhisel-Broadbent J, Dintzis HM, Dintzis RZ, Sampson HA: Allergenicity and antigenicity of chicken egg ovomucoid (Gal d III) compared with ovalbumin (Gal d I) in children with egg allergy and in mice. J Allergy Clin Immunol 1994;93:1047–1059.
3.
Tariq SM, Stevens M, Matthews S, Ridout S, Twiselton R, Hide DW: Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ 1996;313:514–517.
4.
Sicherer SH, Furlong TJ, Munoz-Furlong A, Burks AW, Sampson HA: A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001;108:128–132.
5.
Davoren M, Peake J: Cashew nut allergy is associated with a high risk of anaphylaxis. Arch Dis Child 2005;90:1084–1085.
6.
Clark AT, Anagnostou K, Ewan PW: Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 children. Allergy 2007;62:913–916.
7.
Rance F, Bidat E, Bourrier T, Sabouraud D: Cashew allergy: observations of 42 children without associated peanut allergy. Allergy 2003;58:1311–1314.
8.
Barre A, Sordet C, Culerrier R, Rance F, Didier A, Rouge P: Vicilin allergens of peanut and tree nuts (walnut, hazelnut and cashew nut) share structurally related IgE-binding epitopes. Mol Immunol 2008;45:1231–1240.
9.
Li H, Zhang H: Hypersensitivity of cashew nut. Chin Med Sci J 1997;12:189–192.
10.
Hourihane JO, Harris H, Langton-Hewer S, Kilburn SA, Warner JO: Clinical features of cashew allergy. Allergy 2001;56:252–253.
11.
Quercia O, Rafanelli S, Marsigli L, Foschi FG, Stefanini GF: Unexpected anaphylaxis to cashew nut. Allergy 1999;54:895–897.
12.
Goetz DW, Whisman BA, Goetz AD: Cross-reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific IgE serologic surveys. Ann Allergy Asthma Immunol 2005;95:45–52.
13.
Ferdman RM, Ong PY, Church JA: Pectin anaphylaxis and possible association with cashew allergy. Ann Allergy Asthma Immunol 2006;97:759–760.
14.
Wang LF, Lin JY, Hsieh KH, Lin RH: Epicutaneous exposure of protein antigen induces a predominant th2-like response with high IgE production in mice. J Immunol 1996;156:4077–4082.
15.
Birmingham N, Payankaulam S, Thanesvorakul S, Stefura B, HayGlass K, Gangur V: An ELISA-based method for measurement of food-specific IgE antibody in mouse serum: an alternative to the passive cutaneous anaphylaxis assay. J Immunol Methods 2003;275:89–98.
16.
Li XM, Serebrisky D, Lee SY, Huang CK, Bardina L, Schofield BH, Stanley JS, Burks AW, Bannon GA, Sampson HA: A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 2000;106:150–158.
17.
Rempel JD, Lewkowich IP, HayGlass KT: Endogenous IL-12 synthesis is not required to prevent hyperexpression of type 2 cytokine and antibody responses. Eur J Immunol 2000;30:347–355.
18.
Birmingham NP, Parvataneni S, Hassan HM, Harkema J, Samineni S, Navuluri L, Kelly CJ, Gangur V: An adjuvant-free mouse model of tree nut allergy using hazelnut as a model tree nut. Int Arch Allergy Immunol 2007;144:203–210.
19.
Navuluri L, Parvataneni S, Hassan H, Birmingham NP, Kelly C, Gangur V: Allergic and anaphylactic response to sesame seeds in mice: identification of Ses i 3 and basic subunit of 11s globulins as allergens. Int Arch Allergy Immunol 2006;140:270–276.
20.
Tsuchiya T, Nishimura Y, Nishiuma T, Kotani Y, Funada Y, Yoshimura S, Yokoyama M: Airway remodeling of murine chronic antigen exposure model. J Asthma 2003;40:935–944.
21.
Yang X, HayGlass KT: IFN-gamma, but not IL-4, synthesis by antigen-primed murine T cells is IL-2 dependent. Differential requirements in de novo and established responses. J Immunol 1993;150:4354–4363.
22.
Hsieh KY, Tsai CC, Wu CH, Lin RH: Epicutaneous exposure to protein antigen and food allergy. Clin Exp Allergy 2003;33:1067–1075.
23.
Strid J, Hourihane J, Kimber I, Callard R, Strobel S: Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy 2005;35:757–766.
24.
Adel-Patient K, Bernard H, Ah-Leung S, Creminon C, Wal JM: Peanut- and cow’s milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin. Allergy 2005;60:658–664.
25.
Li XM, Schofield BH, Huang CK, Kleiner GI, Sampson HA: A murine model of IgE-mediated cow’s milk hypersensitivity. J Allergy Clin Immunol 1999;103:206–214.
26.
Snider DP, Marshall JS, Perdue MH, Liang H: Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J Immunol 1994;153:647–657.
27.
Hayday K, Shannon S: Are early exposures linked with childhood peanut allergy? J Fam Pract 2003;52:516–517.
28.
Lack G, Fox D, Northstone K, Golding J: Factors associated with the development of peanut allergy in childhood. N Engl J Med 2003;348:977–985.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.